MedPath

External radiotherapy versus expectancy in localized prostate cancer

Phase 3
Completed
Conditions
Cancer
Prostate cancer
Malignant neoplasm of prostate
Registration Number
ISRCTN36505257
Lead Sponsor
meå University Hospital (Sweden)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
320
Inclusion Criteria

1. Patients with verified localized prostate cancer, T1-T2b, pN0, Grade 1 and 2, M0
2. Age less than or equal to 75 years
3. Surgical obturatorious lymph node staging, with no signs of positive lymph nodes
4. No signs on metastasis after clinical investigation, bone scan and pulmonary X-ray
5. No previous treatment against their prostate cancer
6. No other known malign or benign disease that would shorten their life?s in relation to a healthy population
7. Patients approval of participation

Exclusion Criteria

Patients not willing to participate in the long follow up program

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath